Hida T - Search Results

1

Prognostic role of neutrophil to lymphocyte ratio in advanced melanoma treated with anti-programmed death-1 therapy.

Minowa T, Kato J, Hida T, Horimoto K, Sato S, Sawada M, Uhara H. Minowa T, et al. Among authors: hida t. J Dermatol. 2018 Sep;45(9):e250-e251. doi: 10.1111/1346-8138.14297. Epub 2018 Mar 23. J Dermatol. 2018. PMID: 29572922 No abstract available.

2

Development of sarcoidosis during β-interferon therapy for melanoma.

Shiki M, Hida T, Yamashita T. Shiki M, et al. Among authors: hida t. J Dermatol. 2014 Sep;41(9):862-3. doi: 10.1111/1346-8138.12581. Epub 2014 Aug 11. J Dermatol. 2014. PMID: 25109321 No abstract available.

3

Circulating melanoma cells as a potential biomarker to detect metastasis and evaluate prognosis.

Hida T, Yoneta A, Wakamatsu K, Yanagisawa K, Ishii-Osai Y, Kan Y, Kato J, Yamashita T. Hida T, et al. Australas J Dermatol. 2016 May;57(2):145-9. doi: 10.1111/ajd.12455. Epub 2016 Mar 1. Australas J Dermatol. 2016. PMID: 26931184

4

Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma.

Yoshikawa M, Sumikawa Y, Hida T, Kamiya T, Kase K, Ishii-Osai Y, Kato J, Kan Y, Kamiya S, Sato Y, Yamashita T. Yoshikawa M, et al. Among authors: hida t. J Dermatol. 2017 May;44(5):582-587. doi: 10.1111/1346-8138.13694. Epub 2016 Nov 24. J Dermatol. 2017. PMID: 27882588

5

Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's disease.

Kato J, Sumikawa Y, Hida T, Kamiya T, Horimoto K, Kamiya S, Sato S, Takahashi H, Sawada M, Yamashita T. Kato J, et al. Among authors: hida t. J Dermatol. 2017 Jun;44(6):666-670. doi: 10.1111/1346-8138.13760. Epub 2017 Feb 2. J Dermatol. 2017. PMID: 28150330

6

An adult case of cardiofaciocutaneous syndrome with BRAF mutation.

Sato S, Hida T, Okura M, Ishikawa A, Yamashita T. Sato S, et al. Among authors: hida t. Eur J Dermatol. 2017 Aug 1;27(4):412-413. doi: 10.1684/ejd.2017.3017. Eur J Dermatol. 2017. PMID: 28524057 No abstract available.

7

Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two cases.

Kato J, Hida T, Yamashita T, Kamiya S, Horimoto K, Sato S, Takahashi H, Sawada M, Yamada M, Uhara H. Kato J, et al. Among authors: hida t. J Dermatol. 2018 Jan;45(1):80-82. doi: 10.1111/1346-8138.14017. Epub 2017 Sep 11. J Dermatol. 2018. PMID: 28891079

8

Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.

Sawada M, Kato J, Yamashita T, Yoneta A, Hida T, Horimoto K, Sato S, Uhara H. Sawada M, et al. Among authors: hida t. J Dermatol. 2018 Feb;45(2):216-219. doi: 10.1111/1346-8138.14117. Epub 2017 Nov 8. J Dermatol. 2018. PMID: 29115681 Clinical Trial.

9

Dermoscopic features distinctive for extraocular sebaceous carcinoma.

Horimoto K, Kato J, Sumikawa Y, Hida T, Kamiya T, Sato S, Takahashi H, Sawada M, Yamashita T, Uhara H. Horimoto K, et al. Among authors: hida t. J Dermatol. 2018 Apr;45(4):487-490. doi: 10.1111/1346-8138.14170. Epub 2017 Dec 13. J Dermatol. 2018. PMID: 29235655

10

Cytokeratin 19 expression is a risk factor for metastasis in cutaneous squamous cell carcinoma.

Kato J, Hida T, Sugita S, Hasegawa T, Kamiya S, Horimoto K, Sato S, Sawada M, Uhara H. Kato J, et al. Among authors: hida t. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e299-e301. doi: 10.1111/jdv.14845. Epub 2018 Mar 5. J Eur Acad Dermatol Venereol. 2018. PMID: 29419901 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

669 results

Search Page

Filters